Mayo Clinic ophthalmologist Wayne Wu explains how diabetic retinopathy develops, why regular screening matters and what care can help protect vision.
Understanding And Treating Diabetic Retinopathy
Browsing Category
Medication & Medical Management
197 posts
Next-Gen Anticoagulant Lands FDA Nod For Secondary Stroke Prevention
The FDA approved asundexian with antiplatelet therapy for certain adults after ischemic stroke or high-risk TIA, based on the OCEANIC-Stroke trial.
MedWatch Alert: FDA Requires Safety Labeling Changes For Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due To Potential Increased Risk Of Rare But Serious Eye Condition: FDA Safety Communication
The FDA is requiring GLP-1 drug labels to warn of a potential increased risk of NAION, a rare eye condition that can cause lasting vision loss.
Common Osteoporosis Drugs Linked To 24% Lower Dementia Risk In Major Study
A Hong Kong study of more than 120,000 older adults found lower dementia risk among users of nitrogen-containing bisphosphonates, but cannot prove cause.
Ditching Primary Prevention Statins In Old Age? Technically ‘Safe’ With Caveats
The STREAM trial found statin withdrawal met its two-year non-inferiority test, but cardiovascular events were numerically higher and quality of life did not improve.
Taking A Heartburn Pill Or A Water Pill? Ask About Your Magnesium
Long-term use of some proton pump inhibitors and diuretics can affect magnesium. NIH and FDA guidance explains testing and what patients should ask.
Financing The Newest Hearing Aids
A Hearing Review report outlines how hearing-care practices can discuss financing as patients weigh advanced hearing-aid features and cost.
ReSound Sensia Now Available To US Veterans Through VA Audiology Clinics
GN says veterans can now access ReSound Sensia hearing aids through VA audiology clinics nationwide, including rechargeable, battery-powered and custom styles.
Screened For Diabetes At 23 BMI, Denied GLP-1s Until 30 BMI
A South Asian physician describes being screened for diabetes at BMI 23 but denied GLP-1 coverage at BMI 26.5 under common U.S. criteria.
A New Framework For Safe, Patient-centered Prescribing Of Obesity Medications In Older Adults
The American Geriatrics Society outlines patient-centered checks and support for prescribing obesity medications to older adults.
